pneumologie
130265;140295
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Pneumologie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
About this journal
Media
Authors
Instructions for Authors
Subscription
Subscription Information
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Issues
Current Issue
Free Sample Issue (01/2024)
Related Journals
DMW - Deutsche Medizinische Wochenschrift
Related Books
Innere Medizin: Pneumologie
Innere Medizin: Allgemein
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Ö
Yadao, A
Once-daily indacaterol/glycopyrronium reduces the rate and risk of moderate or severe exacerbations compared with twice-daily salmeterol/fluticasone in a subset of gold froup D COPD patients with a history of >= 2 exacerbations or 1 hospitalization: the FLAME study
Yan, L
Longitudinal Modeling of Prebronchodilator FEV1 Response to Benralizumab for Patients with Severe Asthma
Yanik, S
Die Zytokinantwort von Leukozyten auf humane Rhinoviren ist bei COPD und Rauchern supprimiert
Modulation der T-Zell- und Monozytenaktivität durch Schweißrauchexposition – Daten aus der Weldox II Studie
Yildirim, A
Wandel in der 2nd-line-Therapie des NSCLC – Einfluss der Immuntherapie auf das Überleben
Young, D
The revised GOLD 2017 COPD categorization in relation to comorbidities
Yu, B
Relationship between Benralizumab Exposure and Asthma Exacerbation Rate for Patients with Severe Asthma
Longitudinal Modeling of Prebronchodilator FEV1 Response to Benralizumab for Patients with Severe Asthma
Yuan, Y
Health Status in Patients With Small Cell Lung Cancer (SCLC) Treated With Nivolumab Alone or Combined With Ipilimumab: CheckMate 032